These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20462063)

  • 1. Clinical biomarker procalcitonin (PCT) and its effect on antibiotic usage.
    Kappes J
    S D Med; 2010 May; 63(5):178-9. PubMed ID: 20462063
    [No Abstract]   [Full Text] [Related]  

  • 2. Procalcitonin in intensive care units: the PRORATA trial.
    Gibot S
    Lancet; 2010 May; 375(9726):1605-6; author reply 1606-7. PubMed ID: 20452514
    [No Abstract]   [Full Text] [Related]  

  • 3. Procalcitonin in intensive care units: the PRORATA trial.
    Landman GW; Kleefstra N
    Lancet; 2010 May; 375(9726):1606; author reply 1606-7. PubMed ID: 20452516
    [No Abstract]   [Full Text] [Related]  

  • 4. Procalcitonin in intensive care units: the PRORATA trial.
    Tarnow-Mordi W; Gebski V
    Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452513
    [No Abstract]   [Full Text] [Related]  

  • 5. Procalcitonin in intensive care units: the PRORATA trial.
    Mokart D; Leone M
    Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452515
    [No Abstract]   [Full Text] [Related]  

  • 6. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Procalcitonin: a reliable marker for the diagnosis and monitoring of the course of bacterial infection].
    Holub M; Rozsypal H; Chalupa P
    Klin Mikrobiol Infekc Lek; 2008 Dec; 14(6):201-8. PubMed ID: 19214953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.
    Schuetz P; Chiappa V; Briel M; Greenwald JL
    Arch Intern Med; 2011 Aug; 171(15):1322-31. PubMed ID: 21824946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of procalcitonin (PCT) determination].
    Kuśnierz-Cabala B; Galicka-Latała D
    Przegl Lek; 2004; 61(9):978-80. PubMed ID: 15803912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host response biomarkers in sepsis: the role of procalcitonin.
    Vincent JL; Van Nuffelen M; Lelubre C
    Methods Mol Biol; 2015; 1237():213-24. PubMed ID: 25319789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin-guided antibiotic use in acute respiratory tract infections.
    Bollu M; Marte-Grau AC; Bobba RK
    Arch Intern Med; 2009 Apr; 169(7):716. PubMed ID: 19365003
    [No Abstract]   [Full Text] [Related]  

  • 14. [Procalcitonin: should it be measured systemically?].
    Luong Ba K; Harbarth S; Carballo S
    Rev Med Suisse; 2013 Oct; 9(402):1881-2, 1884-5. PubMed ID: 24298711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin for guidance of antibiotic therapy.
    Schuetz P; Albrich W; Christ-Crain M; Chastre J; Mueller B
    Expert Rev Anti Infect Ther; 2010 May; 8(5):575-87. PubMed ID: 20455686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin to guide antibiotic therapy in the ICU.
    Bréchot N; Hékimian G; Chastre J; Luyt CE
    Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S19-24. PubMed ID: 26607343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will procalcitonin reduce antibiotic use in intensive care?
    Kollef MH
    Lancet; 2010 Feb; 375(9713):435-6. PubMed ID: 20097416
    [No Abstract]   [Full Text] [Related]  

  • 18. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis.
    Kip MM; Kusters R; IJzerman MJ; Steuten LM
    J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Procalcitonin as a biomarker in infections].
    Christ-Crain M
    Praxis (Bern 1994); 2007 Jun; 96(25-26):1017-21. PubMed ID: 17639964
    [No Abstract]   [Full Text] [Related]  

  • 20. Procalcitonin-guided antibiotic treatment in heart failure.
    Sandek A; Springer J; Habedank D; Brunkhorst F; Anker SD
    Lancet; 2004 May; 363(9420):1555; author reply 1555-6. PubMed ID: 15135615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.